Research & Development



  這是皇帝中軍的標準配置,衛青將配屬給自己的武剛車全部給了雲瑯,曹襄跟霍去病。   劉徹擺手道︰“不妥,在朕封禪泰山的時候,不允許出現民亂,朕會派大使前往武威郡,就地處置。”2014079彩票3d杀码   回到自家的帳篷,兒子跟小狗一樣在他身上嗅來嗅去。2013福利彩票双色球走势图   他沒有半分的氣餒,反而笑容滿面。   雲瑯嘆口氣道︰“如此說來,大將軍的病情不容樂觀是吧?”2013福利彩票开奖视频   曹襄倒吸了一口涼氣道︰“如果陛下將司馬叔父也斬首了呢?”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo